References
Metcalf D (1991) The colony-stimulating factors: discovery to clinical use. Philos Trans R Soc Lond Biol 333: 147–173
Miniero R, Madon E, Artesani L, Busca A, Sandri A, Aglietta M, Ramenghi U (1992) Acute pulmonary failure after the first administration of recombinant human granulocyte-macrophage colony-stimulating factor. Leukemia 6: 352–353
Ogawa M, Masaoka T, Mizoguchi H, Takaku F, Nakashima M (1990) A phase-III study of KRN 8601 (rhG-CSF) on neutropenia induced by chemotherapy for malignant lymphoma — a multi-institutional placebo-controlled double-blind comparative study. Jpn J Cancer Chemother 17: 365–373
Shapiro CL, Yeap BY, Godleski J, Jochelson MS, Shipp MA, Skarin AT, Canellos GP (1991) Drug-related pulmonary toxicity in non-Hodgkin's lymphoma. Cancer 68: 699–670
Yuo A, Kitagawa S, Ohsaka A, Ohta M, Miyazono K, Okabe T, Urabe A, Saito M, Takaku F (1989) Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence. Blood 74: 2144–2149
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Iki, S., Yoshinaga, K., Ohbayashi, Y. et al. Cytotoxic drug-induced pneumonia and possible augmentation by G-CSF — clinical attention. Ann Hematol 66, 217–218 (1993). https://doi.org/10.1007/BF01703240
Issue Date:
DOI: https://doi.org/10.1007/BF01703240